Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Clinical Trial Fundamentals: Study Initiation

Learn how to initiate safe, effective, and compliant clinical trials through guidance on FDA forms, informed consent, HIPAA, IRBs, study meetings, and essential files.

Overview

This module provides practical information to help professionals initiate safe, effective, and compliant clinical trials. It addresses the following components as they relate to clinical trials: select FDA forms, key elements of informed consent, the Health Insurance Portability and Accountability Act (HIPAA), Institutional Review Board (IRB), important meetings, and study files. To enhance learning and illustrate the material covered, a fictitious yet realistic clinical trial study will be discussed throughout the module.

This ICH E6 R3 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma Inc. as necessary to enable mutual recognition of GCP training among trial sponsors.

The module takes an average of 2 hours to complete.

This eLearning module can be purchased individually or as part of the Clinical Trial Fundamentals eLearning Program or Clinical Trial Management Comprehensive eLearning Bundle

Featured topics

  • FDA forms
  • Financial disclosure
  • Informed consent
  • HIPAA
  • Institutional Review Board
  • Important meetings
  • Study files

Who should attend?

  • This module is designed for professionals working for investigative site teams, sponsors, or CROs, including:

    • Physicians
    • Pharmacists
    • Physician assistants
    • Nurse practitioners
    • Research scientists
    • Clinical research professionals
    • Clinical investigators
    • Office coordinators
    • Other professionals involved in clinical trials

      Learning objectives

      • At the conclusion of this course, participants should be able to:

        • List the financial disclosure requirements of the study team.
        • Differentiate between the basic and additional elements of informed consent.
        • Recognize the primary responsibility of the Institutional Review Board and its role in a clinical trial.
        • Distinguish between the investigator meeting and the study initiation meeting in terms of characteristics, meeting topics, and attendees.

        Have an account?

        Be informed and stay engaged.

        Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.